Polymorphic crystal form of a indan2-ylamino-hydroxyethyl-quinolinone maleate derivative as beta-adrenoceptor agonist

Details for Australian Patent Application No. 2007291270 (hide)

Owner Novartis AG

Inventors Monnier, Stephanie; Jordine, Guido; Lohse, Olivier

Agent Davies Collison Cave

Pub. Number AU-A-2007291270

PCT Pub. Number WO2008/025816

Priority 06119895.8 31.08.06 EP

Filing date 30 August 2007

Wipo publication date 6 March 2008

International Classifications

C07D 215/26 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

26 February 2009 PCT application entered the National Phase

  PCT publication WO2008/025816 Priority application(s): WO2008/025816

8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007291274-Card receiving device

2007291260-Method and apparatus for carrier-free deflection electrophoresis